October 30, 2025 — Leads & Copy — Prothena Corporation plc (NASDAQ:PRTA) will release its third quarter and first nine months of 2025 financial results on Thursday, November 6, 2025, after the close of the U.S. financial markets, the company said today.
According to past practice, Prothena will not hold a conference call in conjunction with the financial results release on November 6.
Prothena Corporation plc is a clinical biotechnology company focused on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of neurodegenerative and rare peripheral amyloid diseases. Prothena’s pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including ATTR amyloidosis with cardiomyopathy, Alzheimer’s disease, and Parkinson’s disease. Follow the Company on X (formerly Twitter) @ProthenaCorp.
Source: Prothena Corporation plc
